US FDA Actions On Rx Drug Promos Covered New Territory Last Year

2020-2021 PINK SHEET PERSPECTIVES - Megaphone
FDA issued fewer Rx drug promo enforcement letters in 2020 while initiating six new research projects • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

More from Marketing & Advertising

More from Compliance